ClinicalTrials.Veeva

Menu
S

Szpital Wojewodzki im. Mikolaja Kopernika w Koszalinie | Oddzial Onkologii Klinicznej z Pododdzialem Chemioterapii Jednodniowej

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-1084
Pembrolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

Researchers are looking for new ways to treat people with high-risk muscle-invasive urothelial carcinoma (MIUC). Urothelial carcinoma is a type of bl...

Active, not recruiting
Bladder Cancer
Biological: Intismeran autogene
Biological: Enfortumab Vedotin

This is a study evaluating the safety, pharmacokinetics, and efficacy of calderasib alone, and calderasib plus other combination therapies in partici...

Enrolling
Advanced Solid Tumors
Biological: cetuximab
Drug: carboplatin

Trial sponsors

Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems